Erianin inhibits the oncogenic properties of hepatocellular carcinoma via inducing DNA damage and aberrant mitosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Erianin inhibits the oncogenic properties of hepatocellular carcinoma via inducing DNA damage and aberrant mitosis

Published:2020-12 Issue: Volume:182 Page:114266
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Dong Heng,Wang Menglan,Chang Cunjie,Sun Mengqing,Yang Fan,Li Lina,Feng Mengqing,Zhang Lele,Li Qian,Zhu Yannan,Qiao Yiting,Xie Tian,Chen Jianxiang

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference38 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Chemopreventive strategies in hepatocellular carcinoma;Singh;Nat. Rev. Gastroenterol. Hepatol.,2014

3. Lenvatinib: a review in hepatocellular carcinoma;Al-Salama;Drugs,2019

4. Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight;Lohitesh;Cancer Cell Int.,2018

5. Advances in targeted therapies for hepatocellular carcinoma in the genomic era;Llovet;Nat. Rev. Clin. Oncol.,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on the regulatory and pharmacological mechanism of chemical components of Dendrobium;Heliyon;2024-09

2. Erianin induces ferroptosis in GSCs via REST/LRSAM1 mediated SLC40A1 ubiquitination to overcome TMZ resistance;Cell Death & Disease;2024-07-22

3. Research progress on the pharmacological mechanism, in vivo metabolism and structural modification of Erianin;Biomedicine & Pharmacotherapy;2024-04

4. The Wnt-dependent and Wnt-independent functions of BCL9 in development, tumorigenesis, and immunity: Implications in therapeutic opportunities;Genes & Diseases;2024-03

5. Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology;Aging;2024-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3